Zenkuda™ (tarcocimab tedromer) Demonstrated Superiority Over Sham in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy
Explore the breadth and depth of our late and early-phase retina pipeline
1250 Page Mill RoadPalo Alto, CA 94304United States of America
